P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma

May 1, 2005 |

Clinical Cancer Research. 2005 May 1;11(9):3303-8. [Link] Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA. Department of Pathology, Columbia University…

The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro

May 1, 2005 |

The Journal of Thorscic Cardiovascular Surgery. 2005 May;129 (5):1010-7. [Link] Cole GW Jr, Alleva AM, Reddy RM, Maxhimer JB, Zuo J, Schrump DS, Nguyen DM. Section of Thoracic Oncology, Surgery…

Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase

May 1, 2005 |

Molecular Cancer Therapeutics. May 1, 2005; 4:835-842. [Link] Maria E. Ramos-Nino1, Giovina Vianale2, Tara Sabo-Attwood1, Luciano Mutti3, Camilo Porta4, Nicholas Heintz1 and Brooke T. Mossman1 1 Department of Pathology, University…

Therapeutic options in malignant pleural mesothelioma

May 1, 2005 |

Pneumologie. 2005 May;59(5):337-48. [Link] Serke M, Loddenkemper R. HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Zentrum fur Pneumologie und Thoraxchirurgie. Abstract Malignant pleural mesothelioma may be treated with surgery, radiotherapy…

Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis

May 1, 2005 |

American Journal of Clinical Pathology. 2005 May;123(5):724-37. [Link] Baker PM, Clement PB, Young RH. Abstract Seventy-five malignant mesotheliomas of the peritoneum in women were reviewed to highlight their morphologic spectrum.…

Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence

May 1, 2005 |

Thorax 2005;60:433-436. [Link] P A Hessel1, J F Gamble2 and J C McDonald3 1 546 E Delgado Dr, Palatine, IL 60074, USA 2 566 Elizabeth Ave, Somerset, NJ 08873, USA…

Asbestos and mesothelioma: worldwide trends

April 20, 2005 |

Lung Cancer. 2005 Jul;49 Suppl 1:S3-8. Epub 2005 Apr 20. [Link] Kazan-Allen L. International Ban Asbestos Secretariat, P.O. Box 93, Stanmore, Great Britain HA7 4GR, UK. laurie@Ikaz.demon.co.uk Abstract A correlation…

SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study

April 15, 2005 |

Cancer Research 65, No. 8 (2005): 3049-3052. http://cancerres.aacrjournals.org/cgi/content/abstract/65/8/3049 Alfonso Cristaudo1, Rudy Foddis1, Agnese Vivaldi1, Rodolfo Buselli1, Vittorio Gattini1, Giovanni Guglielmi1, Francesca Cosentino1, Franco Ottenga1, Eugenio Ciancia2, Roberta Libener3, Rosangela Filiberti4,…

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

April 11, 2005 |

Annals of Oncology 2005 16(6):923-927. [Link] C. Manegold1,*, J. Symanowski2, U. Gatzemeier3, M. Reck3, J. von Pawel4, C. Kortsik5, K. Nackaerts6, P. Lianes7 and N. J. Vogelzang8 1 Heidelberg University…

Epidemic of mesothelioma in Egypt

April 7, 2005 |

Lung Cancer. 2005 Jul;49 Suppl 1:S17-20. Epub 2005 Apr 7. [Link] Gaafar RM, Eldin NH. Department of Medical Oncology, NCI, Cairo University, Cairo, Egypt. rababgaafar@link.net Abstract Asbestos has been recognized…

Categories